REV1 is implicated in the development of carcinogen-induced lung cancer.
about
Unconventional Ubiquitin Recognition by the Ubiquitin-Binding Motif within the Y Family DNA Polymerases ι and Rev1Structural insights into the assembly of human translesion polymerase complexesStructure and Functional Analysis of the BRCT Domain of Translesion Synthesis DNA Polymerase Rev1Multifaceted Recognition of Vertebrate Rev1 by Translesion Polymerases ζ and κDNA polymerase eta participates in the mutagenic bypass of adducts induced by benzo[a]pyrene diol epoxide in mammalian cellsError-prone translesion synthesis mediates acquired chemoresistanceBoth high-fidelity replicative and low-fidelity Y-family polymerases are involved in DNA rereplicationMolecular chaperone Hsp90 regulates REV1-mediated mutagenesis.Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.Role of selected genetic variants in lung cancer risk in African Americans.DNA polymerases and cancer.Participation of translesion synthesis DNA polymerases in the maintenance of chromosome integrity in yeast Saccharomyces cerevisiae.Overexpression of Rev1 promotes the development of carcinogen-induced intestinal adenomas via accumulation of point mutation and suppression of apoptosis proportionally to the Rev1 expression level.Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?The catalytic function of the Rev1 dCMP transferase is required in a lesion-specific manner for translesion synthesis and base damage-induced mutagenesis.Rev1 contributes to proper mitochondrial function via the PARP-NAD+-SIRT1-PGC1α axis.Translesion synthesis polymerases in the prevention and promotion of carcinogenesis.BPDE-induced genotoxicity: relationship between DNA adducts, mutagenicity in the in vitro PIG-A assay, and the transcriptional response to DNA damage in TK6 cells.Association of polymorphisms in translesion synthesis genes with prognosis of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
P2860
Q27659881-D9964AA0-8E25-4795-87A3-F7CA969AE367Q27675083-4BEFCD93-ABC0-4665-A642-B15F5CB2D665Q27675497-232C5844-72BA-4549-BD79-3C41E4C2AEC8Q27681175-722939D1-1E8F-4FB3-91F5-4480BF0013CDQ28480554-332CE147-E373-4B56-8456-4BC6B3B97D2BQ34376054-386066C4-BE8C-406E-8BBA-3F421BB3926FQ34994632-E8C0EA72-9E39-4222-9675-D3F5AC9BCAC6Q35139973-715075C8-7388-4F55-8788-2427C30AB8EBQ35178418-7A7C0B3A-6FE4-4231-9A17-D115C8035B15Q36759166-A1192259-1611-45F4-9F64-4331A86037FCQ37084895-F0EA9B4C-6331-4DA8-8E38-35ED1F1C655DQ38476459-805C573A-0651-4E22-9AC2-BD9C9C28DB16Q38703688-164E686F-4EB0-4125-A9C2-FF43D3C6C897Q41443583-8956148D-4FF6-42D1-9795-C876D3E1DBBFQ41761731-BCA244F1-3DA0-49C0-873C-C7296F4830E2Q42286102-AB818C0F-0D7A-42F2-A06D-86935FAE7951Q42419243-A160AA13-B935-47D1-B1AF-C6A198AFE0E9Q50042999-215CB69C-EC17-4817-A778-9E3E2228058AQ51570234-962D6D90-B183-4933-A022-AB7202C1BD0C
P2860
REV1 is implicated in the development of carcinogen-induced lung cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
REV1 is implicated in the development of carcinogen-induced lung cancer.
@ast
REV1 is implicated in the development of carcinogen-induced lung cancer.
@en
type
label
REV1 is implicated in the development of carcinogen-induced lung cancer.
@ast
REV1 is implicated in the development of carcinogen-induced lung cancer.
@en
prefLabel
REV1 is implicated in the development of carcinogen-induced lung cancer.
@ast
REV1 is implicated in the development of carcinogen-induced lung cancer.
@en
P2093
P2860
P1476
REV1 is implicated in the development of carcinogen-induced lung cancer.
@en
P2093
Chad A Dumstorf
Elangovan Krishnan
Suparna Mukhopadhyay
W Glenn McGregor
P2860
P304
P356
10.1158/1541-7786.MCR-08-0399
P577
2009-01-27T00:00:00Z